StockData
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. (MRKR) income statement

MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30
$0.85+0.02 (+1.98%)

Close on Nov 18, 2026Market cap $14.23MP/E –Yield –

Marker Therapeutics, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
–
Operating margin
-302.1%
Net margin
-245.5%
Return on equity, FY2025
-68.8%

Financial strength

Current ratio
6.03
Debt to equity
–
Debt to assets
–
Cash to current liabilities
468.2%

Valuation

P/E ratio
–
Price to sales
–
Price to book
1.17
Dividend yield
–

See a number that looks wrong?